GlassScriptPhysician profile
Scott J Davidoff
NPI 1053434399
$35,921.30
in general payments reported to CMS, 2019-2025
48 companies · $716 in 2025
The $716 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $2,411 · 2021: $1,536 · 2022: $693 · 2023: $1,172 · 2024: $1,266 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,153.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $30,627.43 | 2019-2022 | |
| Abbott Laboratories | $1,868.51 | 2019-2025 | Octrode, Eterna, Proclaim |
| Boston Scientific Corporation | $523.69 | 2019-2025 | Intracept, General - Pain Management, Na |
| Vertos Medical, INC. | $252.15 | 2020-2024 | Mild Device Kit |
| Painteq LLC | $244.86 | 2023-2024 | Painteq |
| Curonix LLC | $220.51 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $182.13 | 2020-2024 | Senza, Vyrsa V1 |
| Merz Pharmaceuticals, LLC | $157.13 | 2022-2025 | Xeomin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.88 | 2022-2025 | Relistor |
| Zimmer Biomet Holdings, INC. | $110.71 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Medtronic Vascular, INC. | $87.51 | 2019 | |
| Scilex Pharmaceuticals INC. | $86.74 | 2019-2022 | |
| Nalu Medical, INC. | $85.46 | 2022-2024 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $84.48 | 2022 | |
| Mml US, INC. | $79.29 | 2023-2025 | Reactiv8 |
Show all 46 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Davidoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.